Loading
Latest filing published 05 Jan 2026 for Xilio Therapeutics, Inc..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rene Russo is a declared insider of Xilio Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 1 January 2025 and 1 January 2026, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €21k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises.
Most recently, on 5 January 2026, the filings show an option exercise in Xilio Therapeutics, Inc. The most recent open-market purchase was published on 18 June 2025, 493 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations